HOME >> MEDICINE >> NEWS
Mixed amphetamine salts significantly better than atomoxetine in treating children with ADHD

Irvine, CA, May 4, 2004 In one of the largest ADHD classroom trials conducted to date, children with attention-deficit/hyperactivity disorder (ADHD) achieved significantly greater improvement in both their behavior and attention, the core impairments of ADHD, with extended-release mixed amphetamine salts (MAS XR) compared to those treated with atomoxetine, reported investigators from the University of California, Irvine today at the 157th annual meeting of the American Psychiatric Association (APA) in New York. In the same study, those treated with MAS XR also achieved significantly greater improvement in academic productivity compared to those who received atomoxetine. The comparative St.A.R.T. (Strattera, Adderall XR Randomized Trial) findings also demonstrated similar mild or moderate side effects for the stimulant (MAS XR) and non-stimulant (atomoxetine) medications. This trial provides evidence for the first time of the superior efficacy of extended-release mixed amphetamine salts over atomoxetine in the management of ADHD symptoms.

"Children with ADHD often show impairment throughout the day, whether during school, after-school activities or the evening homework period, so it is welcome news that the extended-release formulation of once-daily mixed amphetamine salts significantly and consistently helped better control children's behavior and attention throughout a 12-hour analog classroom day, compared to atomoxetine, and did so with relatively few side effects," said Sharon Wigal, Ph.D., Director of Clinical Trials at the Child Development Center in the Department of Pediatrics at the University of California, Irvine. "Parents and physicians can use this new information to make an informed choice when selecting ADHD medication to best help their children safely manage ADHD in the social and academic settings they encounter every day."

ADHD affects approximately 3 to 7 percent of all school-age children, or approximately two million chi
'"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6922
Porter Novelli
4-May-2004


Page: 1 2 3 4 5

Related medicine news :

1. Mixed signals to blame for restless legs syndrome
2. Mixed results for study investigating potential of cannabis treatment for MS
3. Testosterone Is Mixed Blessing To Mens Health
4. Mandatory Reporting Of Domestic Violence Cases To Police Has Mixed Support From California Physicians
5. Chemists identify immune system mechanism for methamphetamine binges
6. Crystal methamphetamine use increases HIV risk
7. Methamphetamine withdrawal associated with brain changes seen in mood disorders
8. Methamphetamine, cocaine abusers have different patterns of use
9. Methamphetamine abuse linked to long-term damage to brain cells
10. Yale study of long-term learning deficits resulting from repeated amphetamine exposure could help drug abusers
11. Moving admitted ER patients into inpatient beds faster could significantly increase hospital revenue

Post Your Comments:
(Date:6/17/2013)... A ground-breaking therapy service has been launched in ... , Constraint Therapy Australia celebrated its launch ... program to help people who have suffered a stroke ... other neurological conditions. , Constraint Therapy is the revolutionary ... improve the use of their hand and arm after ...
(Date:6/17/2013)... The distribution of white matter brain ... (MTBI) closely resembles that found in early Alzheimer’s dementia, ... journal Radiology. , “Findings of MTBI bear a ... said the study’s lead author, Saeed Fakhran, M.D., assistant ... the University of Pittsburgh School of Medicine. “Additional research ...
(Date:6/17/2013)... June 18, 2013 Essential tremor (ET) ... an estimated 10 million people in the United States, ... no clear understanding what causes ET, there are no ... no cure. Tulips for Tremor© is the International Essential ... causes of and a cure for this life-altering neurological ...
(Date:6/17/2013)... matter brain abnormalities in some patients after mild traumatic ... Alzheimer,s dementia, according to a new study published online ... of MTBI bear a striking resemblance to those seen ... Saeed Fakhran, M.D., assistant professor of radiology in the ... of Medicine. "Additional research may help further elucidate a ...
(Date:6/17/2013)... Daimer Industries, Inc.®, a well-renowned U.S. based brand ... expertly designed carpet steam cleaner and vapor steam cleaner ... apartment dwellers and homeowners. The commercial steam cleaner can ... pressure levels up to 75 psi to clean most ... clean carpet spots and areas in homes, but it ...
Breaking Medicine News(10 mins):Health News:Revolutionary Treatment for Stroke Now Available in Western Australia 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 2Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 3Health News:RSNA: Concussion Patients Show Alzheimer’s-like Brain Abnormalities 4Health News:International Essential Tremor Foundation Kicks Off Annual Essential Tremor Research Fundraiser, Tulips for Tremor 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 2Health News:Concussion patients show Alzheimer's-like brain abnormalities 3Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 2Health News:Daimer Ships Vapor Steam Cleaner For Homeowners 3
(Date:6/17/2013)... , June 17, 2013 /PRNewswire-iReach/ -- Weiler Labeling ... new X-4S pressure sensitive labeling head. The X-4S ... and performance requirements that serialization demands. ... is uniquely qualified to work with pharmaceutical and ... serialization and track and trace implementation strategies. Designed ...
(Date:6/17/2013)... 17, 2013 /PRNewswire-iReach/ -- United Medical Credit, a top ... gastric bypass and lap band financing and ... effectively contact as many physicians as possible and promote ... all part of the company,s overall goal to bolster ... both good and bad credit to get the help ...
(Date:6/17/2013)... OSAKA, Japan , June 17, 2013 ... wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A. , ... combination therapies KAZANO (alogliptin and metformin HCl) and OSENI ... pharmacies in the United States ... and Drug Administration (FDA) for the treatment of type ...
Breaking Medicine Technology:Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services 2United Medical Credit Hires More Staff to Contact Doctors and Promote their Financing Services 3Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 2Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 3Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 4Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 5Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 6Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 7Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 8Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States 9
Cached News: